Potential of prevention strategies for the modifiable risk factor type 2 diabetes with relation to the future number of dementia patients in Germany- a multi-state projection through 2040.

Fink, Anne; Doerre, Achim; Demuth, Ilja; Doblhammer, Gabriele

Fink, Anne; Doerre, Achim; Demuth, Ilja; Doblhammer, Gabriele.

Affiliation

Fink A; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany. anne.fink@dzne.de.
Doerre A; Robert Koch Institute, Department of Infectious Disease Epidemiology, Berlin, Germany.
Demuth I; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Endocrinology and Metabolic Diseases (including Division of Lipid Metabolism), Biology of Aging working group, Berlin, Germany.
Doblhammer G; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BCRT - Berlin Institute of Health Center for Regenerative Therapies, Berlin, Germany.

BMC Neurol ; 22(1): 157, 2022 Apr 26.

Article in En | MEDLINE | ID: mdl-35468764

Subject(s)

Dementia; Diabetes Mellitus, Type 2; Dementia/epidemiology; Dementia/prevention & control; Diabetes Mellitus, Type 2/epidemiology; Diabetes Mellitus, Type 2/prevention & control; Female; Germany/epidemiology; Humans; Incidence; Male; Prevalence; Risk Factors

Key words

Dementia; Diabetes; Prevention strategies; Projection

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Dementia / Diabetes Mellitus, Type 2 Type of study: Etiology_studies / Incidence_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Country/Region as subject: Europa Language: En Journal: BMC Neurol Journal subject: NEUROLOGIA Year: 2022 Type: Article Affiliation country: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google